Filter by:
Muscular Dystrophy
June 2025
European Medical Journal
Understanding Becker Muscular Dystrophy: Disease Overview & Natural History
Muscular Dystrophy
June 2025
Muscle & Nerve
A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy
Muscular Dystrophy
May 2025
European Medical Journal
Spotlight on Becker Muscular Dystrophy: Understanding the Lived Experience of Becker and Clinical Advancements with a Novel Agent
Muscular Dystrophy
March 2025
2025 MDA Annual Clinical and Scientific Conference
CANYON trial results: Sevasemten, an investigational fast skeletal myosin inhibitor, reduced muscle damage biomarkers and stabilized function in Becker muscular dystrophy (BMD)
Muscular Dystrophy
March 2025
Symposium at the 2025 MDA Annual Clinical and Scientific Conference
Spotlight on Becker Muscular Dystrophy: Understanding the Lived Experience of Becker and Clinical Advancements with a Novel Agent
Muscular Dystrophy
March 2025
2025 MDA Annual Clinical and Scientific Conference
